Nigel M. Stapleton

689 total citations
7 papers, 517 citations indexed

About

Nigel M. Stapleton is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Hematology. According to data from OpenAlex, Nigel M. Stapleton has authored 7 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Molecular Biology and 3 papers in Hematology. Recurrent topics in Nigel M. Stapleton's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (5 papers) and Blood groups and transfusion (3 papers). Nigel M. Stapleton is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (5 papers) and Blood groups and transfusion (3 papers). Nigel M. Stapleton collaborates with scholars based in Netherlands, Norway and United Kingdom. Nigel M. Stapleton's co-authors include Gestur Vidarsson, Annette M. Stemerding, Masja de Haas, C. Ellen van der Schoot, H Einarsdottir, Jan Terje Andersen, Hans Janssen, F.E.M. Rebers, J G van de Winkel and Marion Kleijer and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Nigel M. Stapleton

7 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel M. Stapleton Netherlands 6 353 269 251 81 41 7 517
Annette M. Stemerding Netherlands 7 344 1.0× 292 1.1× 269 1.1× 75 0.9× 45 1.1× 9 588
Ingrid E. van den Herik–Oudijk Netherlands 12 415 1.2× 440 1.6× 234 0.9× 46 0.6× 49 1.2× 12 632
Victoria Martin United Kingdom 7 161 0.5× 402 1.5× 118 0.5× 28 0.3× 35 0.9× 7 542
Shin-ichiro Kashiwamura Japan 7 116 0.3× 436 1.6× 206 0.8× 41 0.5× 39 1.0× 8 568
Heike Danzer Germany 7 169 0.5× 371 1.4× 142 0.6× 22 0.3× 79 1.9× 10 510
W L Carroll United States 11 269 0.8× 353 1.3× 169 0.7× 74 0.9× 123 3.0× 15 588
J E Salmon United States 10 305 0.9× 327 1.2× 201 0.8× 56 0.7× 23 0.6× 14 580
Magdalena Sips United States 11 110 0.3× 245 0.9× 92 0.4× 16 0.2× 35 0.9× 17 444
Rosanne Wisniewolski United States 8 164 0.5× 158 0.6× 212 0.8× 40 0.5× 22 0.5× 10 470
Henrike Reinhard Germany 13 94 0.3× 259 1.0× 118 0.5× 107 1.3× 121 3.0× 20 515

Countries citing papers authored by Nigel M. Stapleton

Since Specialization
Citations

This map shows the geographic impact of Nigel M. Stapleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel M. Stapleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel M. Stapleton more than expected).

Fields of papers citing papers by Nigel M. Stapleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel M. Stapleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel M. Stapleton. The network helps show where Nigel M. Stapleton may publish in the future.

Co-authorship network of co-authors of Nigel M. Stapleton

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel M. Stapleton. A scholar is included among the top collaborators of Nigel M. Stapleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel M. Stapleton. Nigel M. Stapleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Stapleton, Nigel M., Maximilian Brinkhaus, Kathryn L. Armour, et al.. (2019). Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge. Scientific Reports. 9(1). 7363–7363. 26 indexed citations
2.
Stapleton, Nigel M., Sylvia Armstrong‐Fisher, Jan Terje Andersen, et al.. (2018). Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport. Molecular Immunology. 95. 1–9. 16 indexed citations
3.
Stapleton, Nigel M., H Einarsdottir, Annette M. Stemerding, & Gestur Vidarsson. (2015). The multiple facets of FcRn in immunity. Immunological Reviews. 268(1). 253–268. 75 indexed citations
4.
Einarsdottir, H, Nigel M. Stapleton, Sicco A. Scherjon, et al.. (2014). On the Perplexingly Low Rate of Transport of IgG2 across the Human Placenta. PLoS ONE. 9(9). e108319–e108319. 29 indexed citations
5.
Stapleton, Nigel M., Jan Terje Andersen, Annette M. Stemerding, et al.. (2011). Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nature Communications. 2(1). 599–599. 222 indexed citations
6.
Stapleton, Nigel M., Jan Terje Andersen, Annette M. Stemerding, et al.. (2011). Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. RePEc: Research Papers in Economics. 3 indexed citations
7.
Vidarsson, Gestur, Annette M. Stemerding, Nigel M. Stapleton, et al.. (2006). FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood. 108(10). 3573–3579. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026